{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:58:05Z","timestamp":1790387885414,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["UMO-2023\/49\/B\/NZ5\/00775"],"award-info":[{"award-number":["UMO-2023\/49\/B\/NZ5\/00775"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.redox.2025.103552","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T22:15:35Z","timestamp":1739657735000},"page":"103552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Copper in melanoma: At the crossroad of protumorigenic and anticancer roles"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7751-8966","authenticated-orcid":false,"given":"Natalia","family":"Chrzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2231-3740","authenticated-orcid":false,"given":"Mariusz L.","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C6MT00202A","article-title":"Defining the human copper proteome and analysis of its expression variation in cancers","volume":"9","author":"Blockhuys","year":"2017","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1152\/physrev.00011.2024","article-title":"Mammalian copper homeostasis: physiological roles and molecular mechanisms","volume":"105","author":"Lutsenko","year":"2025","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.redox.2025.103552_bib3","doi-asserted-by":"crossref","first-page":"mfae046","DOI":"10.1093\/mtomcs\/mfae046","article-title":"Emerging perspectives of copper-mediated transcriptional regulation in mammalian cell development","volume":"16","author":"Fitisemanu","year":"2024","journal-title":"Metallomics"},{"key":"10.1016\/j.redox.2025.103552_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.dib.2016.08.021","article-title":"Data on copper level in the blood of patients with normal and abnormal angiography","volume":"9","author":"Amiri","year":"2016","journal-title":"Data Brief"},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4103\/NRR.NRR-D-24-00110","article-title":"Role of copper in central nervous system physiology and pathology","volume":"20","author":"Locatelli","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.redox.2025.103552_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103256","article-title":"Deadly excess copper","volume":"75","author":"Sailer","year":"2024","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib7","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.4103\/NRR.NRR-D-24-00642","article-title":"Copper homeostasis and neurodegenerative diseases","volume":"20","author":"Wang","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-024-07206-3","article-title":"Copper homeostasis and cuproptosis in central nervous system diseases","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9\u201310","key":"10.1016\/j.redox.2025.103552_bib9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s10495-024-01993-y","article-title":"Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases","volume":"29","author":"Yang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.redox.2025.103552_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111634","article-title":"Copper in tumors and the use of copper-based compounds in cancer treatment","volume":"226","author":"da Silva","year":"2022","journal-title":"J. Inorg. Biochem."},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.bbamcr.2012.02.011","article-title":"Charting the travels of copper in eukaryotes from yeast to mammals","volume":"1823","author":"Nevitt","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2006-02-003681","article-title":"The Steap proteins are metalloreductases","volume":"108","author":"Ohgami","year":"2006","journal-title":"Blood"},{"issue":"37","key":"10.1016\/j.redox.2025.103552_bib13","doi-asserted-by":"crossref","first-page":"22558","DOI":"10.1074\/jbc.M115.664565","article-title":"Characterization of a single b-type heme, FAD, and metal binding sites in the transmembrane domain of six-transmembrane epithelial antigen of the prostate (STEAP) family proteins","volume":"290","author":"Kleven","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103552_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.88299","article-title":"Mechanism of stepwise electron transfer in six-transmembrane epithelial antigen of the prostate (STEAP) 1 and 2","volume":"12","author":"Chen","year":"2023","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/C6MT00176A","article-title":"Copper trafficking to the secretory pathway","volume":"8","author":"Lutsenko","year":"2016","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101631","article-title":"Copper(II) import and reduction are dependent on His-Met clusters in the extracellular amino terminus of human copper transporter-1","volume":"298","author":"Kar","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1039\/C5MT00131E","article-title":"The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2)","volume":"7","author":"Tsai","year":"2015","journal-title":"Metallomics"},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1039\/c5mt00097a","article-title":"Copper uptake by DMT1: a compensatory mechanism for CTR1 deficiency in human umbilical vein endothelial cells","volume":"7","author":"Lin","year":"2015","journal-title":"Metallomics"},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib19","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.cmet.2024.07.009","article-title":"Zinc transporter 1 functions in copper uptake and cuproptosis","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118867","article-title":"Getting out what you put in: copper in mitochondria and its impacts on human disease","volume":"1868","author":"Cobine","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"32","key":"10.1016\/j.redox.2025.103552_bib21","doi-asserted-by":"crossref","first-page":"26678","DOI":"10.1074\/jbc.M112.381178","article-title":"Functional partnership of the copper export machinery and glutathione balance in human cells","volume":"287","author":"Hatori","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.redox.2025.103552_bib22","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1021\/acs.jpcb.4c01026","article-title":"Unraveling copper exchange in the Atox1-Cu(I)-Mnk1 heterodimer: a simulation approach","volume":"128","author":"Fortino","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.redox.2025.103552_bib23","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/ncomms3430","article-title":"Human copper chaperone for superoxide dismutase 1 mediates its own oxidation-dependent import into mitochondria","volume":"4","author":"Suzuki","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib24","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1074\/jbc.RA118.005283","article-title":"The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation","volume":"294","author":"Boyd","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1074\/jbc.RA117.000265","article-title":"The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis","volume":"293","author":"Boulet","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: from transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.redox.2025.103552_bib27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","article-title":"Targeting cuproplasia and cuproptosis in cancer","volume":"21","author":"Tang","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.redox.2025.103552_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216157","article-title":"Cope with copper: from copper linked mechanisms to copper-based clinical cancer therapies","volume":"561","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2025.103552_bib29","article-title":"Involvement of copper in cell death and cancer","author":"Xie","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.redox.2025.103552_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.70001","article-title":"Cuproplasia and cuproptosis, two sides of the coin","author":"Lu","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.redox.2025.103552_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101900","article-title":"Are trace element concentrations suitable biomarkers for the diagnosis of cancer?","volume":"42","author":"Lossow","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103552_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102728","article-title":"Serum copper, zinc and copper\/zinc ratio in relation to survival after breast cancer diagnosis: a prospective multicenter cohort study","volume":"63","author":"Bengtsson","year":"2023","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jtemb.2005.06.002","article-title":"Trace elements and melanoma","volume":"19","author":"Bergomi","year":"2005","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.redox.2025.103552_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.930041","article-title":"Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/ijms21031069","article-title":"Current biomedical use of copper chelation therapy","volume":"21","author":"Baldari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103552_bib36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10495-012-0746-x","article-title":"D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis","volume":"17","author":"Qiao","year":"2012","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","article-title":"Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma","volume":"22","author":"Tsang","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-148X.2009.00653.x","article-title":"Fifteen-year quest for microphthalmia-associated transcription factor target genes","volume":"23","author":"Cheli","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib39","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/ijms24021601","article-title":"Phenotype switching and the melanoma microenvironment; impact on immunotherapy and drug resistance","volume":"24","author":"Hossain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/jid.2014.319","article-title":"Pro-survival role of MITF in melanoma","volume":"135","author":"Hartman","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.redox.2025.103552_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101753","article-title":"Adaptive redox homeostasis in cutaneous melanoma","volume":"37","author":"Arslanbaeva","year":"2020","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/pcmr.13165","article-title":"The metabolism of melanin synthesis-From melanocytes to melanoma","volume":"37","author":"Snyman","year":"2024","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129273","article-title":"Membrane-associated transporter protein (MATP) regulates melanosomal pH and influences tyrosinase activity","volume":"10","author":"Bin","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib44","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","article-title":"Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy","volume":"123","author":"Brozyna","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/pcmr.12225","article-title":"Inulavosin and its benzo-derivatives, melanogenesis inhibitors, target the copper loading mechanism to the active site of tyrosinase","volume":"27","author":"Fujita","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib46","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/jid.2014.461","article-title":"Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking","volume":"135","author":"Matsui","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbrc.2018.12.105","article-title":"Azepine derivative T4FAT, a new copper chelator, inhibits tyrosinase","volume":"509","author":"Okajima","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdermsci.2017.11.004","article-title":"A novel anti-melanogenic agent, KDZ-001, inhibits tyrosinase enzymatic activity","volume":"89","author":"Hwang","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.redox.2025.103552_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114454","article-title":"The anti-melanogenic effects of ellagic acid through induction of autophagy in melanocytes and suppression of UVA-activated \u03b1-MSH pathways via Nrf2 activation in keratinocytes","volume":"185","author":"Yang","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s42003-023-04640-5","article-title":"Pigmentation and TYRP1 expression are mediated by zinc through the early secretory pathway-resident ZNT proteins","volume":"6","author":"Wagatsuma","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.redox.2025.103552_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2016.12.010","article-title":"The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition","volume":"73","author":"Amaral","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.redox.2025.103552_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature13180","article-title":"Copper is required for oncogenic BRAF signalling and tumorigenesis","volume":"509","author":"Brady","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.redox.2025.103552_bib53","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/MCB.05722-11","article-title":"A novel role for copper in Ras\/mitogen-activated protein kinase signaling","volume":"32","author":"Turski","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib54","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1039\/c9mt00042a","article-title":"Copper chaperone ATOX1 is required for MAPK signaling and growth in BRAF mutation-positive melanoma","volume":"11","author":"Kim","year":"2019","journal-title":"Metallomics"},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101314","article-title":"The copper chaperone CCS facilitates copper binding to MEK1\/2 to promote kinase activation","volume":"297","author":"Grasso","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103552_bib56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1476-4598-8-104","article-title":"Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions","volume":"8","author":"Mills","year":"2009","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib57","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/jid.2011.141","article-title":"HIF-1\u03b1 in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders","volume":"131","author":"Rezvani","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.redox.2025.103552_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111873","article-title":"The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma","volume":"141","author":"Malekan","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.redox.2025.103552_bib59","article-title":"Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1\u03b1 in cancer cells","volume":"15","author":"Kim","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1039\/C8MT00280K","article-title":"Copper affects the binding of HIF-1\u03b1 to the critical motifs of its target genes","volume":"11","author":"Wu","year":"2019","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2008.03.001","article-title":"The release of fibroblast growth factor-1 from melanoma cells requires copper ions and is mediated by phosphatidylinositol 3-kinase\/Akt intracellular signaling pathway","volume":"267","author":"Di Serio","year":"2008","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1075","article-title":"N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3","volume":"12","author":"Shi","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.redox.2025.103552_bib63","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41418-017-0030-2","article-title":"Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability","volume":"25","author":"Santamar\u00eda","year":"2018","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2011.08.132","article-title":"Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells","volume":"413","author":"Haase-Kohn","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2025.103552_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100691","article-title":"Metallothionein isoforms as double agents - their roles in carcinogenesis, cancer progression and chemoresistance","volume":"52","author":"Merlos Rodrigo","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bjc.6603028","article-title":"Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients","volume":"94","author":"Weinlich","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.redox.2025.103552_bib67","doi-asserted-by":"crossref","first-page":"19507","DOI":"10.1073\/pnas.1318431110","article-title":"Bioavailable copper modulates oxidative phosphorylation and growth of tumors","volume":"110","author":"Ishida","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.redox.2025.103552_bib68","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3389\/fonc.2020.00722","article-title":"Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment","volume":"10","author":"Avagliano","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.redox.2025.103552_bib69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41416-020-01159-y","article-title":"Mitochondrial oxidative phosphorylation in cutaneous melanoma","volume":"124","author":"Kumar","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.redox.2025.103552_bib70","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.3390\/cancers13225810","article-title":"Metabolic plasticity in melanoma progression and response to oncogene targeted therapies","volume":"13","author":"Alkaraki","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2025.103552_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.930250","article-title":"Connecting metabolic rewiring with phenotype switching in melanoma","volume":"10","author":"Falletta","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib72","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib73","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmed.2014.12.007","article-title":"Molecular drivers of cellular metabolic reprogramming in melanoma","volume":"21","author":"Abildgaard","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib74","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3390\/cells10113197","article-title":"Mitochondrial metabolism in melanoma","volume":"10","author":"Huang","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib75","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.3390\/ijms19113447","article-title":"PGC-1\u03b1 as a pivotal factor in lipid and metabolic regulation","volume":"19","author":"Cheng","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib76","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1074\/jbc.M104728200","article-title":"Biochemical characterization of the human copper transporter Ctr1","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103552_bib77","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.redox.2018.03.007","article-title":"Copper accumulation in senescent cells: interplay between copper transporters and impaired autophagy","volume":"16","author":"Masaldan","year":"2018","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib78","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3390\/ijms21082980","article-title":"Non-apoptotic cell death signaling pathways in melanoma","volume":"21","author":"Hartman","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib79","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","article-title":"Elesclomol induces cancer cell apoptosis through oxidative stress","volume":"7","author":"Kirshner","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"issue":"10","key":"10.1016\/j.redox.2025.103552_bib80","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","article-title":"The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells","volume":"52","author":"Nagai","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103552_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113253","article-title":"DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11\/GPX4-mediated ferroptosis","volume":"225","author":"Li","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"16","key":"10.1016\/j.redox.2025.103552_bib82","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1021\/ja109413c","article-title":"Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells","volume":"133","author":"Tardito","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib83","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1007\/s12011-024-04072-0","article-title":"Copper and melanoma risk: results from NHANES 2007-2018 and mendelian randomization analyses","volume":"202","author":"Wang","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"issue":"5","key":"10.1016\/j.redox.2025.103552_bib84","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2967\/jnumed.113.133850","article-title":"Theranostics of malignant melanoma with 64CuCl2","volume":"55","author":"Qin","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.redox.2025.103552_bib85","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12011-018-1605-6","article-title":"A new insight on activation of human endogenous retroviruses (HERVs) in malignant melanoma upon exposure to CuSO4","volume":"191","author":"Karimi","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.redox.2025.103552_bib86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2015.05.007","article-title":"Reactivity of dinuclear copper(II) complexes towards melanoma cells: correlation with its stability, tyrosinase mimicking and nuclease activity","volume":"149","author":"Nunes","year":"2015","journal-title":"J. Inorg. Biochem."},{"issue":"10","key":"10.1016\/j.redox.2025.103552_bib87","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2016.07.018","article-title":"In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines","volume":"123","author":"Borges","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.redox.2025.103552_bib88","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1039\/C8DT00794B","article-title":"Hypotoxic copper complexes with potent anti-metastatic and anti-angiogenic activities against cancer cells","volume":"47","author":"Shi","year":"2022","journal-title":"Dalton Trans."},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib89","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbrc.2020.09.104","article-title":"In vitro and in vivo antitumoral activity of a ternary copper (II) complex","volume":"533","author":"Lopes","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib90","doi-asserted-by":"crossref","first-page":"mfab074","DOI":"10.1093\/mtomcs\/mfab074","article-title":"The ionophore thiomaltol induces rapid lysosomal accumulation of copper and apoptosis in melanoma","volume":"14","author":"Scrivner","year":"2022","journal-title":"Metallomics"},{"issue":"6586","key":"10.1016\/j.redox.2025.103552_bib91","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12967-025-06121-1","article-title":"Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications","volume":"23","author":"Cong","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.redox.2025.103552_bib93","article-title":"Cuproptosis: a copper-mediated programmed cell death","volume":"9","author":"Meena","year":"2024","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.redox.2025.103552_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102891","article-title":"Novel insights into anticancer mechanisms of elesclomol: more than a prooxidant drug","volume":"67","author":"Gao","year":"2023","journal-title":"Redox Biol."},{"issue":"15","key":"10.1016\/j.redox.2025.103552_bib95","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/cmdc.202100172","article-title":"Copper: an intracellular achilles' heel allowing the targeting of epigenetics, kinase pathways, and cell metabolism in cancer therapeutics","volume":"16","author":"Michniewicz","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.redox.2025.103552_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103260","article-title":"Tumor microenvironment activation amplify oxidative stress promoting tumor energy remodeling for mild photothermal therapy and cuproptosis","volume":"75","author":"Qiao","year":"2024","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105046","article-title":"FDX1 regulates cellular protein lipoylation through direct binding to LIAS","volume":"299","author":"Dreishpoon","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103552_bib98","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","article-title":"Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease","volume":"42","author":"Rowland","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"20","key":"10.1016\/j.redox.2025.103552_bib99","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","article-title":"Lipoic acid metabolism and mitochondrial redox regulation","volume":"293","author":"Solmonson","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41392-022-01014-x","article-title":"Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41419-024-06691-w","article-title":"The crosstalk between mitochondrial quality control and metal-dependent cell death","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","article-title":"The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm","volume":"22","author":"Vo","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.redox.2025.103552_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.841814","article-title":"Selective targeting of cancer cells by copper ionophores: an overview","volume":"9","author":"Oliveri","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s13577-023-00985-5","article-title":"Copper in Cancer: from transition metal to potential target","volume":"37","author":"Fang","year":"2024","journal-title":"Hum. Cell"},{"key":"10.1016\/j.redox.2025.103552_bib105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.34133\/bmr.0094","article-title":"Copper-based nanomedicines for cuproptosis-mediated effective cancer treatment","volume":"28","author":"Noh","year":"2024","journal-title":"Biomater. Res."},{"key":"10.1016\/j.redox.2025.103552_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2024.127526","article-title":"Advancements in breast cancer therapy: the promise of copper nanoparticles","volume":"86","author":"Surya","year":"2024","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.redox.2025.103552_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114163","article-title":"Recent advances of copper-based metal phenolic networks in biomedical applications","volume":"244","author":"Zhang","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"5","key":"10.1016\/j.redox.2025.103552_bib108","article-title":"Recent advances in copper homeostasis-involved tumor Theranostics","volume":"19","author":"Ren","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.redox.2025.103552_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122805","article-title":"Harnessing nanomaterials for copper-induced cell death","volume":"313","author":"Li","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.redox.2025.103552_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106942","article-title":"Copper-coordinated nanomedicine for the concurrent treatment of lung cancer through the induction of cuproptosis and apoptosis","volume":"204","author":"Huang","year":"2025","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.redox.2025.103552_bib111","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biotno.2024.06.001","article-title":"The potential of copper oxide nanoparticles in nanomedicine: a comprehensive review","volume":"5","author":"Devaraji","year":"2024","journal-title":"Biotechnol. Notes"},{"key":"10.1016\/j.redox.2025.103552_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122763","article-title":"A cuproptosis-based nanomedicine suppresses triple negative breast cancers by regulating tumor microenvironment and eliminating cancer stem cells","volume":"313","author":"Xiao","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cbi.2013.08.005","article-title":"De novo galectin-3 expression influences the response of melanoma cells to isatin-Schiff base copper (II) complex-induced oxidative stimulus","volume":"206","author":"Borges","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib114","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1038\/cddis.2013.314","article-title":"Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-020-0156-4","article-title":"Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2025.103552_bib116","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.actbio.2023.01.010","article-title":"A copper-metal organic framework enhances the photothermal and chemodynamic properties of polydopamine for melanoma therapy","volume":"158","author":"Liu","year":"2023","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib117","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3390\/ijms24032688","article-title":"Copper (II) species with improved anti-melanoma and antibacterial activity by inclusion in \u03b2-cyclodextrin","volume":"24","author":"Tirsoaga","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"28","key":"10.1016\/j.redox.2025.103552_bib118","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1039\/D4NR01857E","article-title":"Copper nitroprusside analogue nanoparticles against melanoma: detailed in vitro and in vivo investigation","volume":"16","author":"Tripathy","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.redox.2025.103552_bib119","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.biopha.2017.10.167","article-title":"Synthesis and characterization of copper nanoparticles stabilized with Quisqualis indica extract: evaluation of its cytotoxicity and apoptosis in B16F10 melanoma cells","volume":"97","author":"Mukhopadhyay","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"38","key":"10.1016\/j.redox.2025.103552_bib120","article-title":"A stimulus-responsive ternary heterojunction boosting oxidative stress, cuproptosis for melanoma therapy","volume":"20","author":"Huang","year":"2024","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib121","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/acsnano.7b08928","article-title":"Copper silicate hollow microspheres-incorporated scaffolds for chemo-photothermal therapy of melanoma and tissue healing","volume":"12","author":"Yu","year":"2018","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib122","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jid.2016.06.625","article-title":"Reactive oxygen species dictate the apoptotic response of melanoma cells to TH588","volume":"136","author":"Wang","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.redox.2025.103552_bib123","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.freeradbiomed.2024.01.019","article-title":"Redox modulation of oxidatively-induced DNA damage by ascorbate enhances both in vitro and ex-vivo DNA damage formation and cell death in melanoma cells","volume":"213","author":"Najeeb","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040690","article-title":"Mitochondrial respiration - an important therapeutic target in melanoma","volume":"7","author":"Barbi de Moura","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029798","article-title":"Mitochondrial electron transport is the cellular target of the oncology drug elesclomol","volume":"7","author":"Blackman","year":"2012","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.redox.2025.103552_bib126","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1158\/0008-5472.CAN-12-0979","article-title":"Inactivation of the HIF-1\u03b1\/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants","volume":"72","author":"Kluza","year":"2012","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib127","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/exd.12718","article-title":"Combining BRAF(V) (600E) inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma","volume":"24","author":"Livingstone","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.redox.2025.103552_bib128","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.18632\/oncotarget.1420","article-title":"Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor","volume":"4","author":"Corazao-Rozas","year":"2013","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/exd.12613","article-title":"Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations","volume":"24","author":"Cierlitza","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"32","key":"10.1016\/j.redox.2025.103552_bib130","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1200\/JCO.2008.17.1579","article-title":"Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma","volume":"27","author":"O'Day","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib131","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","article-title":"Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma","volume":"31","author":"O'Day","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.redox.2025.103552_bib132","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2025.103552_bib133","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1038\/s41388-022-02364-0","article-title":"Copper ionophore elesclomol selectively targets GNAQ\/11-mutant uveal melanoma","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib134","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00280-020-04216-8","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"87","author":"Lu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.redox.2025.103552_bib135","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/CM9.0000000000002909","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"137","author":"Zeng","year":"2024","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib136","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CMR.0b013e328334131d","article-title":"Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma","volume":"20","author":"Morrison","year":"2010","journal-title":"Melanoma Res."},{"issue":"8","key":"10.1016\/j.redox.2025.103552_bib137","first-page":"890","article-title":"Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS\/BRAF mutations and c-MYC\/p53 status","volume":"13","author":"Calderon-Aparicio","year":"2019","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib138","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-023-02941-5","article-title":"Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy","volume":"43","author":"Meraz-Torres","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103552_bib139","doi-asserted-by":"crossref","first-page":"40348","DOI":"10.18632\/oncotarget.9613","article-title":"Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics","volume":"7","author":"Fernandez Del Ama","year":"2016","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.redox.2025.103552_bib140","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1002\/cam4.3346","article-title":"Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu2+ in a mice model","volume":"9","author":"Hu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.redox.2025.103552_bib141","doi-asserted-by":"crossref","first-page":"29771","DOI":"10.18632\/oncotarget.4833","article-title":"Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate","volume":"6","author":"Calderon-Aparicio","year":"2015","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.redox.2025.103552_bib142","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110636","article-title":"Disulfiram bolsters T-cell anti-tumor immunity through direct activation of LCK-mediated TCR signaling","volume":"41","author":"Wang","year":"2022","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.redox.2025.103552_bib143","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007487","article-title":"Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD\/VISTA axis","volume":"11","author":"Chen","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.redox.2025.103552_bib144","first-page":"1266","article-title":"Anticancer drug disulfiram for in situ RAFT polymerization: controlled polymerization, multifacet self-assembly, and efficient drug delivery, ACS macro","volume":"5","author":"Zhou","year":"2016","journal-title":"Letture"},{"key":"10.1016\/j.redox.2025.103552_bib145","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1039\/D4RA01075B","article-title":"Self-supplying Cu2+ and H2O2 synergistically enhancing disulfiram-mediated melanoma chemotherapy","volume":"19","author":"Gao","year":"2024","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib146","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40199-024-00527-w","article-title":"Preparation of poly(vinyl alcohol) nanofibers containing disulfiram-copper complex by electrospinning: a potential delivery system against melanoma","volume":"32","author":"El Fawal","year":"2024","journal-title":"Daru"},{"key":"10.1016\/j.redox.2025.103552_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103007","article-title":"Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib148","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.det.2022.07.007","article-title":"Targeted therapy and immunotherapy in melanoma","volume":"41","author":"Lazaroff","year":"2023","journal-title":"Dermatol. Clin."},{"issue":"5","key":"10.1016\/j.redox.2025.103552_bib149","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.hoc.2024.05.006","article-title":"Targeted therapy innovations for melanoma","volume":"38","author":"Amarillo","year":"2024","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib150","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/cancers15041106","article-title":"Immunotherapy in melanoma: recent advances and future directions","volume":"15","author":"Knight","year":"2023","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.redox.2025.103552_bib151","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11864-024-01279-0","article-title":"Advances in understanding drug resistance mechanisms and innovative clinical treatments for melanoma","volume":"25","author":"He","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.redox.2025.103552_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177142","article-title":"A comprehensive review of targeting RAF kinase in cancer","volume":"986","author":"Hossain","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2025.103552_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104426","article-title":"Evolving cancer resistance to anti-PD-1\/PD-L1 antibodies in melanoma: comprehensive insights with future prospects","volume":"201","author":"Li","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib154","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-023-36979-y","article-title":"The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma","volume":"14","author":"Lim","year":"2023","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.redox.2025.103552_bib155","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1158\/0008-5472.CAN-16-1190","article-title":"Copper chelation inhibits brafv600e-driven melanomagenesis and counters resistance to BRAFV600E and MEK1\/2 inhibitors","volume":"77","author":"Brady","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.redox.2025.103552_bib156","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/mmt-2015-0005","article-title":"Copper suppression as cancer therapy: the rationale for copper chelating agents in BRAFV600 mutated melanoma","volume":"3","author":"Sammons","year":"2016","journal-title":"Melanoma Manag"},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112570","article-title":"Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF\/MEK inhibition in melanoma","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib158","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbrc.2016.07.026","article-title":"Detention of copper by sulfur nanoparticles inhibits the proliferation of A375 malignant melanoma and MCF-7 breast cancer cells","volume":"477","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.redox.2025.103552_bib159","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.devcel.2024.06.018","article-title":"Don't fear the reaper: the role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy","volume":"59","author":"La Marca","year":"2024","journal-title":"Dev. Cell"},{"issue":"7","key":"10.1016\/j.redox.2025.103552_bib160","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1158\/0008-5472.CAN-19-1784","article-title":"Inhibition of BCL2 family members increases the efficacy of copper chelation in brafv600e-driven melanoma","volume":"80","author":"Kim","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib161","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib162","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/cells9092013","article-title":"Targeting oxidative phosphorylation reverses drug resistance in cancer cells by blocking autophagy recycling","volume":"9","author":"Lee","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib163","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40478-019-0712-8","article-title":"Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis","volume":"7","author":"Sundstr\u00f8m","year":"2019","journal-title":"Acta Neuropathol. Commun"},{"key":"10.1016\/j.redox.2025.103552_bib164","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41419-020-2662-2","article-title":"POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK\/ERK pathway activation and MITF up-regulation","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103552_bib165","article-title":"Plasticity of drug-na\u00efve and vemurafenib- or trametinib-resistant melanoma cells in execution of differentiation\/pigmentation program","volume":"2019","author":"Czyz","year":"2019","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.redox.2025.103552_bib166","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/15548627.2017.1332550","article-title":"An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells","volume":"13","author":"Martin","year":"2017","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.redox.2025.103552_bib167","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1541-7786.MCR-22-0684","article-title":"Targeting ULK1 decreases ifn\u03b3-mediated resistance to immune checkpoint inhibitors","volume":"21","author":"Fenton","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"19","key":"10.1016\/j.redox.2025.103552_bib168","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib169","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41181-024-00243-5","article-title":"Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands","volume":"9","author":"Krutzek","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70385-8","article-title":"Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models","volume":"14","author":"Bansal","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.redox.2025.103552_bib171","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7150\/thno.102556","article-title":"MRI guided copper deprivator activated immune responses and suppressed angiogenesis for enhanced antitumor immunotherapy","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2025.103552_bib172","doi-asserted-by":"crossref","DOI":"10.1021\/jacs.4c14394","article-title":"Copper chelate targeting externalized phosphatidylserine inhibits PD-L1 expression and enhances cancer immunotherapy","author":"Gao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib173","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12967-023-03891-4","article-title":"Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"16","key":"10.1016\/j.redox.2025.103552_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36324","article-title":"A cuproptosis-related prognostic signature for guiding clinical diagnosis and treatment in uveal melanoma patients","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.redox.2025.103552_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1344755","article-title":"Role of hippo pathway and cuproptosis-related genes in immune infiltration and prognosis of skin cutaneous melanoma","volume":"15","author":"Lv","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.redox.2025.103552_bib176","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309984","article-title":"Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.redox.2025.103552_bib177","article-title":"Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition","volume":"25","author":"Cao","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.redox.2025.103552_bib178","article-title":"PEGylated Elesclomol@Cu(\u2161)-based Metal\u2012organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy","volume":"29","author":"Lu","year":"2024","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.redox.2025.103552_bib179","article-title":"The role of cuproptosis-related gene in the classification and prognosis of melanoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.redox.2025.103552_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411358","article-title":"A newly established cuproptosis-related gene signature for predicting prognosis and immune infiltration in uveal melanoma","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.redox.2025.103552_bib181","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/pcmr.13185","article-title":"The prognostic implications of cuproptosis-related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma","volume":"37","author":"Zhou","year":"2024","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.redox.2025.103552_bib182","article-title":"Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.redox.2025.103552_bib183","article-title":"A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib184","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12672-024-01089-8","article-title":"Cuproptosis-related DNA methylation signature predict prognosis and immune microenvironment in cutaneous melanoma","volume":"15","author":"Zhu","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.redox.2025.103552_bib185","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fonc.2020.00851","article-title":"Metabolic traits in cutaneous melanoma","volume":"10","author":"Neagu","year":"2020","journal-title":"Front. Oncol."},{"issue":"7788","key":"10.1016\/j.redox.2025.103552_bib186","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.redox.2025.103552_bib187","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1158\/0008-5472.CAN-24-1304","article-title":"Warburg effect reshapes tumor immunogenicity","volume":"84","author":"Enr\u00edquez","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2025.103552_bib188","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12943-024-02113-9","article-title":"Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective","volume":"23","author":"Xiao","year":"2024","journal-title":"Mol. Cancer"},{"issue":"24","key":"10.1016\/j.redox.2025.103552_bib189","article-title":"Copper and iron orchestrate cell-state transitions in cancer and immunity","volume":"8924","author":"M\u00fcller","year":"2024","journal-title":"Trends Cell Biol. S0962-"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:54:42Z","timestamp":1742320482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":189,"alternative-id":["S2213231725000655"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103552","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copper in melanoma: At the crossroad of protumorigenic and anticancer roles","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103552"}}